Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 7.0

Eligibility Criteria:
Inclusion Criteria:~* Patients between the ages of 18 to 70 years with Type 2 diabetes who have not been able to adequately control their blood glucose levels~* Note: Only patients who have not been taking any antihyperglycemic medicine for 3 months will be screened~Exclusion Criteria:~* Patients taking any medicines that affect body fluid level such as a diuretic or water pill~* Patients taking niacin or other certain medications~* Patients with any of the following conditions: liver or kidney disease, poorly controlled high blood pressure, heart disease or certain blood disorders~* Patients with abnormal laboratory results from a blood test that will be given before each patient starts the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Part1 - Arm 1 (Type: EXPERIMENTAL): Part1: Arm 1: drug
- Part1 - Arm 2 (Type: PLACEBO_COMPARATOR): Part1 - Arm 2: Pbo comparator
- Part 2 - Arm 1 (Type: PLACEBO_COMPARATOR): Part 2 - Arm 1: Pbo
- Part 2 - Arm 2 (Type: EXPERIMENTAL): Part 2- Arm 2: drug 5mg
- Part 2 - Arm 3 (Type: EXPERIMENTAL): Part 2 - Arm 3: drug 15mg
- Part 2 - Arm 4 (Type: EXPERIMENTAL): Part 2 - Arm 4: drug 30mg
- Part 2 - Arm 5 (Type: ACTIVE_COMPARATOR): Part 2 - Arm 5: active comparator

Based on this trial design, predict the completion outcome and termination type (if applicable).